Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Advanced Solid Tumors With MAPK Pathway Mutations
Clinical Trial
NCT05886920Last updated: 12/16/2025
WXI
WUXI
Analgesia
Pulmonary Hypertension
Knee Osteoarthritis
Glabellar Frown Lines
AGA